580-22-3 | 2-Aminoquinoline

Packsize	Purity	Availability	Price	Discounted Price
250mg	97%	in stock	$9.00	$6.00
1g	97%	in stock	$13.00	$9.00
5g	97%	in stock	$24.00	$17.00
10g	97%	in stock	$47.00	$33.00
25g	97%	in stock	$117.00	$82.00
100g	97%	in stock	$467.00	$327.00

Description

• Catalog Number: AB53174
• Chemical Name: 2-Aminoquinoline
• CAS Number: 580-22-3
• Molecular Formula: C9H8N2
• Molecular Weight: 144.1732
• MDL Number: MFCD00038079
• SMILES: Nc1ccc2c(n1)cccc2

Computed Properties

• Complexity: 136
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 1
• XLogP3: 1.9

Literature

• Lys05: a new lysosomal autophagy inhibitor.

  Autophagy 20120901

• Aminoquinolines as fluorescent labels for hydrophilic interaction liquid chromatography of oligosaccharides.

  Biological chemistry 20120801

• One-pot synthesis of 2-aminoquinoline-based alkaloids from acetonitrile.

  Organic & biomolecular chemistry 20120714

• Synthesis of aminoquinoline-based aminoalcohols and oxazolidinones and their antiplasmodial activity.

  Chemical biology & drug design 20120301

• Proton grease: an acid accelerated molecular rotor.

  Journal of the American Chemical Society 20120227

• Reactions of substituted pyridines with electrophilic boranes.

  Dalton transactions (Cambridge, England : 2003) 20120221

• Different 8-hydroxyquinolines protect models of TDP-43 protein, α-synuclein, and polyglutamine proteotoxicity through distinct mechanisms.

  The Journal of biological chemistry 20120203

• Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni.

  PLoS neglected tropical diseases 20120201

• Synthetic peroxides as potent antimalarials. News and views.

  Current topics in medicinal chemistry 20120101

• Novel binding mode of a potent and selective tankyrase inhibitor.

  PloS one 20120101

• Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites.

  PloS one 20120101

• A chelation enhanced selective fluorescence sensing of Hg2+ by a simple quinoline substituted tripodal amide receptor.

  Dalton transactions (Cambridge, England : 2003) 20111214

• Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.

  The Journal of infectious diseases 20111115

• Comprehensive profiling and quantitation of amine group containing metabolites.

  Analytical chemistry 20111001

• From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).

  Journal of medicinal chemistry 20110825

• A residue W756 in the P-loop segment of the sodium channel is critical for primaquine binding.

  European journal of pharmacology 20110801

• Palladium(II) complexes of quinolinylaminophosphonates: synthesis, structural characterization, antitumor and antimicrobial activity.

  Journal of inorganic biochemistry 20110601

• {N,N'-[2,2'-(Ethane-1,2-diyldisulfanediyl)di-o-phenyl-ene]bis-(quinoline-2-carboxamidato)}copper(II).

  Acta crystallographica. Section E, Structure reports online 20110601

• Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.

  Current genomics 20110601

• Highly sensitive MALDI analyses of glycans by a new aminoquinoline-labeling method using 3-aminoquinoline/α-cyano-4-hydroxycinnamic acid liquid matrix.

  Analytical chemistry 20110515

• Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids.

  Bioorganic & medicinal chemistry letters 20110315

• Acridine and acridinones: old and new structures with antimalarial activity.

  The open medicinal chemistry journal 20110101

• Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations.

  Malaria journal 20110101

• PfMDR1: mechanisms of transport modulation by functional polymorphisms.

  PloS one 20110101

• Redox-based inactivation of cysteine cathepsins by compounds containing the 4-aminophenol moiety.

  PloS one 20110101

• A girl with cutaneous lesions, polyarthritis, and antinuclear antibodies positivity.

  ISRN dermatology 20110101

• Molecular-field-based three-dimensional similarity studies on quinoline-based CNS active agents.

  ISRN pharmaceutics 20110101

• Synthesis and structure of azole-fused indeno[2,1-c]quinolines and their anti-mycobacterial properties.

  Organic & biomolecular chemistry 20101221

• Reactivity of the bifunctional ambiphilic molecule 8-(dimesitylboryl)quinoline: hydrolysis and coordination to Cu(I), Ag(I) and Pd(II).

  Dalton transactions (Cambridge, England : 2003) 20101207

• Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds.

  Bioorganic & medicinal chemistry 20101201

• Synthesis and anti-prion activity evaluation of aminoquinoline analogues.

  European journal of medicinal chemistry 20101101

• Synthesis and in vitro antiproliferative activity of 5-alkyl-12(H)-quino[3,4-b] [1,4]benzothiazinium salts.

  European journal of medicinal chemistry 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• N-[(2-Chloro-8-methyl-quinolin-3-yl)meth-yl]-4-meth-oxy-aniline.

  Acta crystallographica. Section E, Structure reports online 20101101

• Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase.

  Molecular pharmacology 20101001

• Solution behavior of hematin under acidic conditions and implications for its interactions with chloroquine.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20100901

• Resonance Raman characterization of the different forms of ground-state 8-substituted 7-hydroxyquinoline caged acetate compounds in aqueous solutions.

  The journal of physical chemistry. A 20100225

• A programmed cell death pathway in the malaria parasite Plasmodium falciparum has general features of mammalian apoptosis but is mediated by clan CA cysteine proteases.

  Cell death & disease 20100201

• Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity.

  Annals of clinical microbiology and antimicrobials 20100101

• Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors.

  PloS one 20100101

• Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria.

  PloS one 20100101

• Fluorescent chemosensors for toxic organophosphorus pesticides: a review.

  Sensors (Basel, Switzerland) 20100101

• Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation.

  European journal of medicinal chemistry 20090801

• Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.

  Experimental parasitology 20090701

• Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.

  Bioorganic & medicinal chemistry letters 20090701

• Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry 20090701

• Aminoquinoline derivatives with antiproliferative activity against melanoma cell line.

  Bioorganic & medicinal chemistry letters 20090701

• Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.

  The American journal of tropical medicine and hygiene 20090401

• Two complementary fluorimetric assays for the determination of aminoquinoline binding and uptake by human erythrocytes in vitro.

  Analytical biochemistry 20090215

• Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.

  Inorganic chemistry 20090202

• Malarial parasite pathogenesis and drug targets.

  F1000 biology reports 20090101

• Sequential and selective Buchwald-Hartwig amination reactions for the controlled functionalization of 6-bromo-2-chloroquinoline: synthesis of ligands for the Tec Src homology 3 domain.

  The Journal of organic chemistry 20081121

• 4-N-, 4-S-, and 4-O-chloroquine analogues: influence of side chain length and quinolyl nitrogen pKa on activity vs chloroquine resistant malaria.

  Journal of medicinal chemistry 20080626

• A highly efficient and selective turn-on fluorescent sensor for Cu2+ ion based on calix[4]arene bearing four iminoquinoline subunits on the upper rim.

  Chemical communications (Cambridge, England) 20080421

• Determination of oseltamivir quality by colorimetric and liquid chromatographic methods.

  Emerging infectious diseases 20080401

• Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines.

  Bioorganic & medicinal chemistry letters 20080115

• Hybrid molecules with a dual mode of action: dream or reality?

  Accounts of chemical research 20080101

• Metallocene antimalarials: the continuing quest.

  Metal-based drugs 20080101

• The prince and the pauper. A tale of anticancer targeted agents.

  Molecular cancer 20080101

• Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues.

  Bioorganic & medicinal chemistry letters 20071201

• Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligands.

  Journal of medicinal chemistry 20071004

• Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SK(Ca)).

  Bioorganic & medicinal chemistry 20070815

• Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists.

  Bioorganic & medicinal chemistry letters 20070801

• A Cl- anion-responsive luminescent Eu3+ complex with a chiral tripod: ligand substituent effects on ternary complex stoichiometry and anion sensing selectivity.

  Dalton transactions (Cambridge, England : 2003) 20070714

• Picosecond time-resolved fluorescence study on solute-solvent interaction of 2-aminoquinoline in room-temperature ionic liquids: aromaticity of imidazolium-based ionic liquids.

  The journal of physical chemistry. B 20070510

• Application of fragment screening by X-ray crystallography to beta-secretase.

  Journal of medicinal chemistry 20070322

• Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretase.

  Journal of medicinal chemistry 20070322

• Quinazoline and benzimidazole MCH-1R antagonists.

  Bioorganic & medicinal chemistry letters 20070301

• Crystal and molecular structures of trichloro-cobalt(II) complexes of epiquinine, epiquinidine, and epidihydrocinchonine.

  Chirality 20070201

• Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers.

  PLoS clinical trials 20070101

• World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.

  Malaria journal 20070101

• Aminoquinoline melanin-concentrating hormone 1-receptor (MCH1-R) antagonists.

  Current topics in medicinal chemistry 20070101

• Excited-state proton transfer through water bridges and structure of hydrogen-bonded complexes in 1H-pyrrolo[3,2-h]quinoline: adiabatic time-dependent density functional theory study.

  The journal of physical chemistry. A 20061102

• 2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.

  Bioorganic & medicinal chemistry letters 20061015

• Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol.

  Bioorganic & medicinal chemistry 20060815

• Base-displaced intercalated structure of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in the recognition sequence of the NarI restriction enzyme, a hotspot for -2 bp deletions.

  Journal of the American Chemical Society 20060809

• A dynamic tricopper double helicate.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20060515

• Quinolactacins revisited: from lactams to imide and beyond.

  Organic & biomolecular chemistry 20060421

• Sensitive fluorescence HPLC assay for AQ-13, a candidate aminoquinoline antimalarial, that also detects chloroquine and N-dealkylated metabolites.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060403

• Three 4-aminoquinolines of antimalarial interest.

  Acta crystallographica. Section C, Crystal structure communications 20060201

• Synthesis of N-benzylated-2-aminoquinolines as ligands for the Tec SH3 domain.

  Bioorganic & medicinal chemistry letters 20060115

• Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia.

  Malaria journal 20060101

• The use of genotyping in antimalarial clinical trials: a systematic review of published studies from 1995-2005.

  Malaria journal 20060101

• Synthesis of C-nucleosides designed to participate in triplex formation with native DNA: specific recognition of an A:T base pair in DNA.

  The Journal of organic chemistry 20051028

• Structure-function studies on a synthetic guanosine receptor that simultaneously binds Watson-Crick and Hoogsteen sites.

  The Journal of organic chemistry 20050916

• Synthesis of 5-, 6- and 7-substituted-2-aminoquinolines as SH3 domain ligands.

  Organic & biomolecular chemistry 20050721

• Steric effect on the nuclease activity of Cu(II) complexes with aminoquinoline derivatives.

  Journal of inorganic biochemistry 20050701

• Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.

  Autoimmunity reviews 20050601

• Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase.

  Bioorganic & medicinal chemistry letters 20050415

• [Unwanted reactions to modifying antirheumatic drugs].

  Terapevticheskii arkhiv 20050101

• Identification and specificity studies of small-molecule ligands for SH3 protein domains.

  Journal of medicinal chemistry 20041021

• Electrospray/mass spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs) produced by Pseudomonas aeruginosa.

  Journal of the American Society for Mass Spectrometry 20040601

• Molecular complexes of IQ and 4-hydroxy-coumarin: a mutagen-anti-mutagen system.

  Journal of photochemistry and photobiology. B, Biology 20040527

• Synthesis and antimalarial activity of trioxaquine derivatives.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20040402

• 4-Aryl(benzyl)amino-4-heteroarylbut-1-enes as building blocks in heterocyclic synthesis. 4. Synthesis of 4, 6-dimethyl-5-nitro(amino)-2-pyridylquinolines and their antiparasitic activities.

  Archiv der Pharmazie 20040301

• Antimalarial lichenoid tissue reactions in patients with pre-existing lupus erythematosus.

  Lupus 20040101

• Genomics research and malaria control: great expectations.

  PLoS biology 20031101

• Synthesis, characterization and antitumor activity of platinum(II) complexes with diethyl and monoethyl 2-quinolylmethylphosphonates.

  Journal of inorganic biochemistry 20030701

• Chloroquine and artemisinin: six decades of research--what next?

  IDrugs : the investigational drugs journal 20030701

• Electrochemical study of hydroxychloroquine and its determination in plaquenil by differential pulse voltammetry.

  Journal of pharmaceutical and biomedical analysis 20030601

• Imidazole derivatives as a novel class of hybrid compounds with inhibitory histamine N-methyltransferase potencies and histamine hH3 receptor affinities.

  Bioorganic & medicinal chemistry 20030515

• Conductometric and indirect AAS determination of antimalarials.

  Journal of pharmaceutical and biomedical analysis 20030326

• Severe malaria in a splenectomised Gabonese woman.

  Wiener klinische Wochenschrift 20030131

• Novel zinc fluorescent probe bearing dansyl and aminoquinoline groups.

  Chemical communications (Cambridge, England) 20020707

• Characterization of a didehydrobenzoxazine intermediate in a novel carbene-to-carbene transformation.

  Journal of the American Chemical Society 20020703

• Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects.

  Dermatologic clinics 20020701

• 3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.

  Biochemistry 20020305

• Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.

  Journal of medicinal chemistry 20020227

• Dissociation and electrooxidation of primaquine diphosphate as an approach to the study of anti-chagas prodrugs mechanism of action.

  Bioelectrochemistry (Amsterdam, Netherlands) 20010101

• Genetic toxicology testing of the antimalarial drugs chloroquine and a new analog, AQ-13.

  Environmental and molecular mutagenesis 20010101